Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gold Bond is a leading consumer healthcare brand specializing in medicated skin care products. Founded in 1882, the brand is widely recognized for its medicated body powders and has expanded into a comprehensive line of lotions, creams, and ointments targeting various dermatological conditions. Its products address concerns such as dry skin, eczema, psoriasis, and minor skin irritations using active ingredients like menthol, salicylic acid, and colloidal oatmeal. Currently owned by Sanofi, Gold Bond operates within the global consumer healthcare market, providing over-the-counter solutions for skin health and protection. The brand is managed under Sanofi's Consumer Healthcare business unit, headquartered in Chattanooga, Tennessee.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gold Bond.